Produkty 481-25-4

CAS 481-25-4 występuje w naszej ofercie pod nazwami: Cholesterol Impurity 21, Lopenol. Oferty producentów: Hubei YoungXin, GLPBio. Dostępne opakowania: 10mg, 25mg, 50mg, 100mg, 200mg, 250ug,2,5mg.

Cholesterol Impurity 21
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
Lopenol
GLPBio
  • opakowanie: 250ug,2,5mg
  • Warianty: 1
od 2516,04
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CAS 481-25-4) to związek chemiczny o wzorze sumarycznym C28H48O i masie molowej 400.7 g/mol. Nazwa systematyczna IUPAC: (3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol. InChIKey: LMYZQUNLYGJIHI-SPONXPENSA-N.

Dane identyfikacyjne
Wzór sumarycznyC28H48O
Masa molowa400.7 g/mol
Nazwa IUPAC(3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKeyLMYZQUNLYGJIHI-SPONXPENSA-N
SMILESC[C@@H]1[C@H](CC[C@]2([C@H]1CC=C3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4[C@H](C)CCCC(C)C)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Lophenol, 4alpha-Methyl-5alpha-cholest-7-en-3beta-ol, Cholest-7-en-3-ol, 4-methyl-, (3beta,4alpha,5alpha)-, Methostenol, 4-Methylcholest-7-en-3-ol, 4alpha-methyl-cholest-7-en-3beta-ol, Cholest-7-en-3-ol, 4-methyl-, (3.beta.,4.alpha.,5.alpha.)-, orb1740279, 4-Methylcholest-7-en-3-ol #, LMYZQUNLYGJIHI-SPONXPENSA-N
Powiązane formy tego związku
(3R,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
Izomery (ten sam wzór sumaryczny)
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,4R,8S,9S,10R,13R,14S,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,4S,8S,9S,10R,13R,14S,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C28H48O
(3S,4S,5S,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-5-methyl-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O